2012 Genetics Conferences
Genetics — New Treatments, New Research, New Dilemmas
July 28: Austin, TX — Barton Creek Resort
August 4: San Antonio, TX — Westin La Cantera
August 11: Dallas, TX — Westin Galleria
Texas DSHS Newborn Screening Unit and Genetics has partnered with Cardea to bring you our 2012 Genetics Conference.
Physicians, nurse practitioners, nurses, and clinical staff who attend this conference will learn about new tests and treatments available to patients with genetic disorders, identify local resources for genetic referrals and discuss the ethical dilemmas that are brought about with these new technologies.
Each site has a small room block at the special conference rate. Use the registration link to the right to find more about the rates and how to reserve a hotel room.
Check in for the conferences will begin at 8:30 am Central. Each conference will start at 9:30 am and end at 5:00 pm. A reception will be held directly following the event where you can network with the speakers and other experts in the field.
Who should attend?
Physicians, nurses, nurse practitioners, PAs, CNMs, genetic counselors and others who may encounter patients with genetic disorders. Fields include, but are not limited to: general/family practice, pediatrics, and OB/Gyn, Genetics.
Continuing Education (CME)
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Texas Medical Association (TMA) through the joint sponsorship of Seton Healthcare Family and Cardea Services. The Seton Healthcare Family is accredited by TMA to provide continuing medical education for physicians.
The Seton Healthcare Family designates this educational activity for a maximum of 5.5 AMA PRA Category 1 credit(s)™. Physicians should claim only credit commensurate with the extent of their participation.
The presentation, Dilemmas in Genetic Treatment/Diagnosis, has been designated for 1 credit of education in medical ethics and/or professional responsibility.
Continuing Nursing Education (CNE)
Cardea Services is an approved provider of continuing nursing education by the Texas Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.
Upon successful completion of each session of this educational activity 5.5 continuing nursing education hours will be awarded.
Successful completion of this continuing nursing education activity includes the following:
- Being registered for this activity;
- Completing the sign in and Verification of Attendance form;
- Being present no later than five (5) minutes after starting time;
- Remaining until the scheduled ending time of each session; and
- Completing and submitting the evaluation form(s).
Topics and Objectives
Overview of Emerging Therapies for Genetic Disorders
- Cite the Texas rates for birth defects
- Discuss how new advances in the treatment of genetic disorders will affect screening and referrals to genetic specialists
Treatment for Skeletal Dysplasia and Connective Tissue Disorders
- List available tests of connective tissue disorders and skeletal dysplasias
- Describe new treatments of connective tissue disorders and skeletal dysplasias
Treatment of Lysosomal Storage Diseases
- Identify the treatment options that are available for Lysosomal Storage Diseases
- Explain the issues in timing the initiation of treatments for presymptomatic patients
Clinical and Treatment Update on Neurofibromatosis (Austin)
- Identify patients with neurofibromatosis who may benefit from new therapeutic approaches and clinical trials
- Recognize when best to refer patients with neurofibromatosis for specialized treatment and subspecialist care
New Treatments for Signaling Defects: Neurofibromatosis (San Antonio and Dallas)
- Identify appropriate new treatments for signaling defects
- Appropriately judge when to make referrals for treatment
Ethics - Dilemmas in Genetic Treatment/Diagnosis
- Define components of ethical reasoning
- Identify ethical challenges of managing genetic diagnoses
Panel Discussion: How Advances in Testing and Treatment of Genetic Disorders Affect Local Practice
- Discuss multiple perspectives on how changes in genetic testing and treatment affect patient care.
- Identify local resources for genetic treatment referrals.
This event is funded by the Texas Department of State Health Services, Contract No. 2012-040124